Most Popular
-
1
Hybe-Ador feud should have limited effect on Hybe's overall performance: analysts
-
2
First-ever meeting of president, opposition chief set to finally happen
-
3
Blinken calls on China to press N. Korea to end its 'dangerous' behavior
-
4
NewJeans' singles, Japanese debut to proceed as planned, despite Hybe-Ador feud
-
5
Experts raise concerns about Japan putting pressure on Naver over Line
-
6
South Korea to launch space security center under spy agency
-
7
More med professors to take day off each week while govt. urges them to stay
-
8
Hybe refutes Ador CEO Min's denial of breach of trust
-
9
S. Korea, Japan could consider simplified entry agreement: Seoul official
-
10
Legoland Korea Resort to open until 9 p.m.
Access Bio receives W2b research support from Gates Foundation
By 윤정현Published : Sept. 8, 2016 - 14:23
[DISCLOSURE] Access Bio (950130) -- which specializes in research, development and manufacturing of in vitro rapid diagnostic tests, biosensor and molecular diagnostic products -- has received 2 billion won (US$ 1.82 million) from the Bill & Melinda Gates Foundation.
The foundation will provide funds until Feb. 1, 2018, to support its research and development to improve sensitivity of malaria diagnostic methods, the company added.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
The foundation will provide funds until Feb. 1, 2018, to support its research and development to improve sensitivity of malaria diagnostic methods, the company added.
By Yun Jeong-hyeon (clareyun@heraldcorp.com)
